dr. tolaney discusses pertuzumab in her2 breast cancer
Published 7 years ago • 151 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:40
dr. tolaney discusses neratinib in her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
1:52
dr. geyer discusses pertuzumab in her2 breast cancer
-
1:08
dr. tolaney discusses the role of chemotherapy in her2 breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:48
dr. tolaney on the evolution of adjuvant treatment for her2 breast cancer
-
1:58
dr. hurvitz discusses role of pertuzumab in her2 breast cancer
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
1:10
dr. tolaney discusses unmet needs in er breast cancer